I'll get right to the point — more people are being diagnosed with Alzheimer's disease each day. As the numbers continue to rise, you have an important role to play in keeping resources available and in the fight for a cure. Changing the trajectory of this disease requires all of us to stand strong together to meet the urgency of this moment.
Despite the challenges, there are reasons for hope.
The U.S. Food and Drug Administration (FDA) has approved treatments that can meaningfully change the progression of the disease for some people living with early Alzheimer's. While there's currently no cure, these treatments may give those living with early Alzheimer's more time to plan for the future, to live independently and to spend more time with family and friends.
New tools and technology are being developed to aid in early diagnosis, including FDA-approved blood-based biomarker testing. While not a standalone test, these blood tests which detect amyloid plaques, a hallmark of Alzheimer's disease, through a simple blood draw, offer a less invasive way to achieve an accurate diagnosis earlier.
Data from U.S. POINTER — an Association-led two-year clinical trial conducted to evaluate whether lifestyle interventions that simultaneously target many risk factors protect cognitive function in older adults who are at risk for cognitive decline — showed that positive actions can make a difference in brain health. The Association will use these promising study results to improve early detection efforts that are critical in qualifying for FDA-approved treatments.
These are positive developments — but we can't stop here. It's going to take all of us to keep moving progress forward and to provide care and support until we find a cure we know is out there. Please join the fight with a gift to our 2026 Annual Fund Drive before it ends on January 30. You'll show your commitment to our mission to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.
Gratefully,
Maria C. Carrillo, Ph.D.
Chief Science Officer and Medical Affairs Lead
Your donation will strengthen our efforts to advance Alzheimer's care, support and research. From face-to-face support to online education programs and promising global research initiatives, your gift makes a difference in the lives of all those affected by Alzheimer's and other dementias in your community and across the world. Thank you for your continued support.
Please add [email protected] to your address book to ensure you receive all future emails.
Having trouble reading this email? View it in your browser
View your email preferences or unsubscribe.
